rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2000-1-28
|
pubmed:abstractText |
Glycyrramum was shown to potentiate the antitumor and antimetastatic effects of cyclophosphamide treatment in mice and rats with transplantable tumors. It also decreased its myelotoxicity. After primary Lewis lung carcinoma was removed glycyrramum treatment significantly inhibited metastacizing processes in mice.
|
pubmed:language |
rus
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0507-3758
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
554-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10629717-Animals,
pubmed-meshheading:10629717-Antineoplastic Agents,
pubmed-meshheading:10629717-Antineoplastic Agents, Alkylating,
pubmed-meshheading:10629717-Carcinoma, Lewis Lung,
pubmed-meshheading:10629717-Cyclophosphamide,
pubmed-meshheading:10629717-Drug Synergism,
pubmed-meshheading:10629717-Female,
pubmed-meshheading:10629717-Glycyrrhetinic Acid,
pubmed-meshheading:10629717-Mice,
pubmed-meshheading:10629717-Mice, Inbred C57BL,
pubmed-meshheading:10629717-Rats
|
pubmed:year |
1999
|
pubmed:articleTitle |
[Glyciram as an enhancer of the effectiveness of chemotherapy and surgery in the treatment of experimental neoplasms].
|
pubmed:affiliation |
Research Institute of Pharmacology, Siberian Branch of Russian Academy of Medical Sciences, Tomsk.
|
pubmed:publicationType |
Journal Article,
English Abstract
|